836 related articles for article (PubMed ID: 11657875)
1. Regulatory orphans: juvenile prisoners as transvulnerable research subjects.
Reed JG
IRB; 1999; 21(2):9-14. PubMed ID: 11657875
[No Abstract] [Full Text] [Related]
2. An IRB member's perspective on access to innovative therapy.
Moore DL
Albany Law Rev; 1994; 57(3):559-81. PubMed ID: 11652854
[No Abstract] [Full Text] [Related]
3. An introduction to NBAC's report on research involving persons with mental disorders that may affect decisionmaking capacity.
Childress JF
Account Res; 1999; 7(2-4):101-15. PubMed ID: 11658169
[No Abstract] [Full Text] [Related]
4. Commission says institutional review boards should change procedures now.
Maloney DM
Hum Res Rep; 1999 Jan; 14(1):1-2. PubMed ID: 11657555
[No Abstract] [Full Text] [Related]
5. National commission proposes numerous new regulations of institutional review boards.
Maloney DM
Hum Res Rep; 1998 Oct; 13(10):1-2. PubMed ID: 11657739
[No Abstract] [Full Text] [Related]
6. Gene therapy in mental retardation: ethical considerations.
Fletcher JC
Ment Retard Dev Disabil Res Rev; 1995; 1():7-13. PubMed ID: 11660293
[No Abstract] [Full Text] [Related]
7. Medical Research Involving Human Subjects Act.
Netherlands
Bull Med Ethics; 1999 Nov; No. 152():13-8. PubMed ID: 11658081
[No Abstract] [Full Text] [Related]
8. DHHS internal policies for reviewing research involving children.
Reatig N
IRB; 1981 Jan; 3(1):1-4. PubMed ID: 11661894
[No Abstract] [Full Text] [Related]
9. Research involving children: an interpretation of the new regulations.
Levine RJ
IRB; 1983; 5(4):1-5. PubMed ID: 11649521
[No Abstract] [Full Text] [Related]
10. True protection for persons with severe mental disabilities, such as schizophrenia, involved as subjects in research? A look and consideration of the "Protection of Human Subjects.
Ryan AJ
J Law Health; 1994-1995; 9(2):349-76. PubMed ID: 11657417
[No Abstract] [Full Text] [Related]
11. The changing clinical trials scene: the role of the IRB.
Mitchell SC; Steingrub J
IRB; 1988; 10(4):1-5. PubMed ID: 11650078
[No Abstract] [Full Text] [Related]
12. Legal and financial encumbrances to clinical research.
Sonnenreich MR
Perspect Biol Med; 1980 Pt 2): S120-S149, Winter; 23(2):. PubMed ID: 11663072
[No Abstract] [Full Text] [Related]
13. Protection of human subjects.
United States
Code Fed Regul Shipping; 1982 Oct; Part 46, Sections 46.101 to 46.306():. PubMed ID: 11660819
[No Abstract] [Full Text] [Related]
14. Parental consent and family planning research involving minors: case study.
Herceg-Baron R
IRB; 1981 Nov; 3(9):5-7. PubMed ID: 11649402
[No Abstract] [Full Text] [Related]
15. Informed consent: the FDA's perspective.
Bagley G
Food Drug Law J; 1993; 48(2):181-6. PubMed ID: 11653141
[No Abstract] [Full Text] [Related]
16. Half-full or half-empty? Evaluating IRB performance.
Mishkin B; Ariand N
Prof Ethics Rep; 1998; 11(3):4-7. PubMed ID: 11657925
[No Abstract] [Full Text] [Related]
17. Research with radiation and healthy children: greater than minimal risk.
Freeman WL
IRB; 1994; 16(5):1-5. PubMed ID: 11652791
[No Abstract] [Full Text] [Related]
18. Special informed consent requirements are included in protocol review procedures.
Maloney DM
Hum Res Rep; 1995 Jul; 10(7):1-2. PubMed ID: 11654274
[No Abstract] [Full Text] [Related]
19. Dangerous intersections.
Korn D
Issues Sci Technol; 1996; 13(1):55-62. PubMed ID: 11654761
[No Abstract] [Full Text] [Related]
20. Regulating research on the terminally ill: a proposal for heightened safeguards.
Addicott DC
J Contemp Health Law Policy; 1999; 15(2):479-524. PubMed ID: 10394764
[No Abstract] [Full Text] [Related]
[Next] [New Search]
